Microsporidia are obligate intracellular parasites that infect eukaryotic cells and have emerged as major opportunistic human pathogens. Due to the difficulties in definitive laboratory diagnosis and insufficient knowledge, ocular microsporidiosis is infrequently reported in India. To improve diagnostic facilities, we have developed a novel duplex PCR (dPCR) for the simultaneous identification of both genera and species of isolates with microsporidian aetiology that cause keratitis. The material scraped from the corneas of 12 clinically diagnosed microsporidial keratitis patients was subjected to routine microbiological examinations and molecular diagnosis using a novel dPCR that targeted the small-subunit rRNA gene (SSU-rRNA) of microsporidia and Vittaforma corneae using genus-and species-specific primers. Of the 12 corneal scrapes, 6 showed positive results in smears, while dPCR provided positive amplification with both panmicrosporidial and V. corneae species-specific primers for 9 corneal scrapes. The results were validated by sequencing and BLAST analysis. The sensitivity of this novel dPCR method was higher than that of conventional microscopy in the diagnosis of corneal microsporidial infection. dPCR with specific primers is potentially more sensitive, specific and depends less on more complicated methods for exact identification of the aetiology of microsporidial keratitis.
INTRODUCTION
Microsporidial infection is an important emerging opportunistic disease, and is caused by a group of obligate intracellular protozoan parasites belonging to the phylum Microspora, in immunocompromised and immunocompetent patients (Didier, 2005; Abreu-Acosta et al., 2005) . Over 1300 species of microsporidia belonging to 160 genera have been described, of which, Nosema and Encephalitozoon are well-known ocular pathogens (Witner & Weiss, 1999; Sharma et al., 2011) . Ocular microsporidiosis has been classified pathologically as either stromal or epithelial, and its pathogenesis varies according to the immune status of the patients (Cali et al. 1991; Schwartz et al., 1993) . Ocular microsporidiosis, although uncommon, occurs mainly in two forms: keratoconjunctivitis form, mostly seen in immunocompromised individuals; and stromal keratitis form, seen in immunocompetent individuals. Although an enormous amount of literature is available on microsporidiosis, knowledge of ocular manifestations is still minimal. In spite of the fact that a variety of diagnostic techniques have been described, laboratory diagnosis still remains difficult, and reports on ocular manifestations, especially in India remain scant (Sharma et al., 2011; Joseph et al., 2006a, b) . Hence, a concerted approach was needed to overcome the shortcomings to allow accurate identification, which has led of late to molecular methods (Fedorko & Hijazi, 1996; Reddy et al., 2011; Joseph et al., 2006c) . A number of conventional species-specific PCR and probe-based real-time PCRs have been used for the detection of different microsporidian species (Menotti et al., 2003; Polley et al., 2011) . In particular, PCR which targets the rRNA gene appears to be superior, because of the high sensitivity and specificity (Joseph et al., 2006c; Fedorko & Hijazi, 1996) . Most of the methods target the small-subunit rRNA gene (SSU-rRNA) to allow detection IP: 54.70.40.11
On: Tue, 18 Dec 2018 00:59:42 of microsporidia; however, the large-subunit rRNA gene and the intergenic spacer region have also been used as the target DNA (Joseph et al., 2006c; Franzen & Müller, 1999 ). An efficient approach for the molecular detection of microsporidia is the construction of universal or pan-microsporidial primers that amplify all major microsporidian pathogens, as well as species-specific primers for microsporidial species reported to cause ocular infections. In this context, we have developed a novel methodology, duplex PCR (dPCR), for rapid simultaneous detection of both genus and species of microsporidia using genus-and speciesspecific primers. The results have been validated by sequencing and through BLAST analysis.
METHODS
Ocular specimens and inclusion of study subjects. This prospective and consecutive analysis included 1270 corneal scrapes that were submitted for microbiological evaluation from patients clinically diagnosed as having infectious keratitis by a group of ophthalmologists. It was based on typical clinical features, such as eyes with a loss of corneal epithelium, with underlying stromal infiltration and suppuration associated with signs of inflammation, with or without hypopyon, seen at the Cornea Clinic of Aravind Eye Hospital & Postgraduate Institute of Ophthalmology, Tirunelveli, Tamil Nadu, India, between October 2010 and September 2011. Ulcers with typical features of viral infection and healing ulcers were excluded, as were Moorens' ulcers, interstitial keratitis, sterile neurotropic ulcers and any other ulcers associated with autoimmune conditions. Among the 1270 patients clinically diagnosed with infectious keratitis, a provisional diagnosis of microsporidial keratitis was made in 12 patients based on their typical clinical features, such as progressive loss of vision, with multiple diffuse, minute, dot or punctate epithelial lesions, sometimes with multiple target-like epithelial lesion evolving into a nummular pattern or mixed follicularpapillary conjunctival reaction. Sometimes a dense greyish stromal infiltrate with or without surrounding oedema was observed (Fig. 1a) , mostly presenting as an atypical viral keratoconjunctivitis or mimicking herpes simplex virus keratitis, and sometimes associated with iritis. Immunocompromised patients typically develop conjunctivitis and an epithelial keratitis accompanied by pain, photophobia, blurred vision, conjunctival hyperaemia and foreign body sensation (Das et al., 2012; Friedberg & Ritterband, 1999) . After detailed ocular examination with a slit-lamp bio-microscope, using standard techniques, corneal scrapes were performed under aseptic conditions for each ulcer by an ophthalmologist using a sterile Bard-Parker (no. 15) blade after instillation of Microscopy photograph of 1 % acid-fast stained smear (stained using a modified Ziehl-Neelsen method) demonstrating, large, oval to round, bright red colour spores of microsporidia (V. corneae) against a paler background (magnification ¾1000). 0.5 % proxymetacaine hydrochloride. The scraped material of the 12 patients who were clinically diagnosed as having microsporidial keratitis was included in the study. Part of the scraped material was subjected to microbiological evaluation such as smear analysis [10 % potassium hydroxide wet mounting, Gram-staining, acid-fast staining, modified Ziehl-Neelsen acid-fast staining (1 % H 2 SO 4 techniques)] and culture analysis (bacterial culture on blood agar supplemented with 5 % sheep's blood, chocolate agar, brain heart infusion broth and thioglycollate medium, fungal cultures on potato dextrose agar and Sabouraud's dextrose broth, and acanthamoebic cultures on non-nutrient agar with Escherichia coli overlay) (Bharathi et al., 2007) . Part of the corneal scrapes from the 12 study subjects was collected in 1.5 ml vials containing 250 ml Tris-EDTA (TE) [16TE 2 10 mM Tris (pH 8.0 with HCl), 1 mM EDTA] buffer for performing dPCR analysis. The protocols mentioned in the manuscript are the routine diagnostic procedures at our institute, and hence Institutional Review Board approval was not necessary.
DNA extraction. Extraction of DNA from the 12 samples from the study subjects and from 4 American Type Culture Collection (ATCC) control strains of microsporidia [Encephalitozoon hellem (ATCC 50504), Encephalitozoon cuniculi (ATCC 50789), Encephalitozoon intestinalis (ATCC 50651) and Vittaforma corneae (ATCC 50505)], were carried out using a QIAamp DNA mini kit (Qiagen) in accordance with the manufacturer's recommendations.
Oligonucleotide primers. Oligonucleotide primers as described by Raynaud et al. (1998) (forward 59-CACCAGGTTGATTCTGCC-39 and reverse 59-GTGACGGGCGGTGTGTAC-39) targeting the SSU-rRNA gene were used for the amplification of the pan-microsporidial genome, and species-specific primers targeting the SSU-rRNA gene of V. corneae were designed using sequences in GenBank with an alignment constructed with the CLUSTAL algorithm contained in MEGALIGN, a component of the sequence analysis package Lasergene (DNASTAR). V. corneae species-specific primers (forward 59-CTAC-CAAGACAGTGACGGTTGA-39 and reverse 59-GGCATCTTTTACT-GCTGGAACT-39) were chosen from divergent regions within the panmicrosporidial amplicon. The analytical specificity of the panmicrosporidial and V. corneae species-specific primer sets was tested using the DNA of bacterial, fungal and acanthamoebic isolates from corneal infections along with the DNA of ATCC strains of microsporidial species and negative controls. Similarly, the analytical sensitivity of both primers was determined using serially diluted DNA (100 ng ml 21 to 100 fg ml 21 ) of V. corneae (ATCC 50505).
Optimization of dPCR and amplification of microsporidial genomes. Reactions (50 ml) for dPCR were optimized in an Eppendorf Mastercycle ProS thermalcycler with PCR reagent mixture consisting of 106buffer [106buffer 2 10 mM Tris-HCl pH 8.3 (at room temperature), 50 mM KCl, 1.5 mM MgCl 2 ], 200 mM each dNTPs, oligonucleotide primer sets (10 pmole each primer), 1 unit Taq DNA polymerase, with or without MgCl 2 (2 mM), 10 ng template DNA from corneal scrapes and/or from positive control strains and sterile water. The dPCR programs consisted of an initial denaturation at 94 uC for 5 min, followed by 30 cycles of DNA denaturation at 94 uC for 45 s, primer annealing at 58 uC for 60 s, and primer extension at 72 uC for 90 s. After the last cycle, a final extension step at 72 uC for 8 min was added and the products were stored at 4 uC. The annealing temperature of both the pan-microsporidial and V. corneae primers was optimized as 58 uC for 60 s. All PCRs were carried out in a 50 ml reaction volume contained in a 0.2 ml thin-walled polypropylene microfuge tube (Eppendorf), using 10 ml DNA from each corneal scrape, in addition, there were three negative controls (DNA extraction control, reagent mixture control and non-infectious vitreous fluid) and one positive control (V. corneae ATCC 50505), after determining the specificity and sensitivity of all the primer sets. The amplicons were resolved in 1.5 % Tris/borate-EDTA agarose gel with ethidium bromide (0.5 mg ml
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), visualized with a UV transilluminator and results recorded with a gel documenting system (Vilber Lourmat). The expected PCR amplicon size was 1200 and 472 bp for pan-microsporidial and V. corneae specific-primers, respectively. A 20 kb DNA ladder (GeNei) was used for comparison.
Sequencing of PCR products. For further confirmation, the PCR products of six study subjects were subjected to sequencing analysis at MWG AG Biotech, Bangalore, India, using an ABI 3730 XI automated sequencer (PE Applied Biosystems) following the manufacturer's instructions. The sequences were analysed and identified using the MEGABLAST search program of the GenBank database. Finally, organism identification was determined by comparing our sequences with existing sequences in the GenBank database using the BLAST program available at the National Center for Biotechnology Information (NCBI) website (http://www.ncbi.nlm.nih.gov). A sequence similarity of ,99 % for the SSU-rRNA gene was the criterion used to define a new bacterial strain.
RESULTS
Of the 12 study subjects, 6 showed positive results for microsporidia in smears (Figs 1b, c, d) , while cultures exhibited negative results for any microbial growth. Smears and cultures of the remaining six study subjects were found to be negative for micro-organisms. DNA amplified with pan-microsporidial primers from all four ATCC strains of microsporidia produced 1200 bp amplicons, while DNA amplified with V. corneae species-specific primers from an ATCC strain of V. corneae alone produced a 472 bp amplicon (Fig. 2a) . None of the primers produced amplicons with bacterial, fungal and acanthamoebic DNA (Fig. 2a) . The lowest concentration at which pan-microsporidial primers amplified DNA from the four ATCC control strains was 10 pg, while V. corneae species-specific primers with DNA of the V. corneae control strain required 1 pg (Fig. 2b) . Of the 12 study subjects, the DNA of 9 (75 %) (of which 6 showed positive results and 3 showed negative results in smears) was amplified positively with both pan-microsporidial primers and V. corneae speciesspecific primers producing 1200 and 472 bp amplicons, respectively (Fig. 2c) . None of the DNA from the remaining three subjects showed any positive amplification. Similarly, neither of the two negative controls showed any positive amplification. DNA sequencing of the six amplicons, followed by a DNA database comparison analysis with a partial sequence of the SSU-rRNA gene of V. corneae identified the isolates as six new strains of V. corneae and the sequences have been deposited in the NCBI GenBank database (accession numbers JQ087416-JQ087421). A sequence similarity of ,99 % for the SSUrRNA gene was the criterion used for defining a new strain.
DISCUSSION
Microsporidia are a diverse group of intracellular eukaryotic parasites that are highly derived relatives of fungi and harbour very small genomes, the most extreme being the 2.3 Mbp genome of E. intestinalis (Peyretaillade et al., 1998) .
In these genomes, the genes are flanked characteristically by short intergenic regions along with few repetitive sequences. Since microsporidians are obligate and intracellular in nature, the numbers of genes present in the genome are severely reduced and are packed into a smaller space with a significant reduction of intergenic space (Katinka et al., 2001; Slamovits et al., 2004; Vivarès & Méténier, 2000) . Although microsporidia are true eukaryotic organisms, the features of the rRNA-encoding DNA resemble prokaryotic sequences (Franzen & Müller, 1999) , and are composed of a 16S SSU-rRNA gene and a 23S LSU-rRNA gene, which are separated by an intergenic non-transcribed spacer. Whereas, true eukaryotic organisms possess a 5.8S rRNA gene, and this is a unique feature of true eukaryotes. In addition to this, the SSU-rRNA and LSU-rRNA genes of microsporidia are shorter than typical eukaryotic SSU-rRNA and LSUrRNA genes, and lack several universal sequences (Franzen & Müller, 1999) . The discovery of a gene for a mitochondrialtype chaperone (Peyretaillade et al., 1998) combined with molecular phylogenetic data, led to microsporidia being reclassified as fungi that have lost mitochondria during evolution ( Van de Peer et al., 2000) .
Several PCR-based methods have been reported for amplifying different regions of the SSU and LSU rRNA genes, as well as the intergenic spacer region, for diagnosis and species differentiation of microsporidia infecting humans (Fedorko & Hijazi, 1996) . SSU-rRNA sequences are used for species-specific detection, as well as for the analysis of the phylogenetic relationship of an organism (Franzen & Müller, 1999) . Hence, to enhance our diagnostic capability, conserved, repetitive and highly variable sequences within the rRNA genes need to be identified that amplify microsporidian genomes specifically. The highly variable sequences of the SSU-rRNA genes provide a unique signature for any microsporidian and useful information about possible relationships (Woese, 1987) , because SSU-rRNA genes accumulate mutations at a low and constant rate over time. The first such report on the use of conserved rRNA primers was for the SSU-rRNA gene of Vairimorpha necatrix, a pathogen of agricultural pests, which indicated that evolutionary development path leading to microsporidia branched very early from that leading to other eukaryotes (Vossbrinck et al., 1987; Ghosh & Weiss, 2009) . Primers complementary to conserved sequences within this gene were used to amplify and subsequently obtain sequence data on the rRNA gene of several human-infecting microsporidia (Zhu et al., 1994; Vossbrinck et al., 1993; Raynaud et al., 1998; Franzen & Müller, 1999; Reddy et al., 2011) . Therefore, such pan-microsporidial primers are very useful in the NC1 NC2 2 3 4 5 6 7 8 9 10 11 12 MW 1 NC 2 3 4 5 6 7 8 9 10 11 12 PC MW 1 NC1 NC2 2 3 4 5 6 7 8 9 10 PC MW 1 Fig. 2 . Amplified products from dPCR primer sets after agarose gel electrophoresis (2 % agarose stained with 0.5 mg ml "1 ethidium bromide), showing 1200 and 472 bp amplicons produced using pan-microsporidial and V. corneae species-specific primer sets, respectively. (a) Evaluation of the analytical specificity of the primer sets. Lane NC1, negative control for DNA extraction; lane NC2, negative control for reagent mixture; lanes 1-8, an absence of bands indicates negative amplification for primer sets with the DNA of Escherichia coli (ATCC 25922), Enterobacter aerogenes (ATCC35028), Klebsiella pneumoniae (ATCC 10031), Haemophilus influenzae type b (ATCC 10211), Pseudomonas aeruginosa (ATCC 35032), Staphylococcus aureus (ATCC 25923), Streptococcus pyogenes (ATCC 12384) and Candida albicans (ATCC 90028), respectively; lanes 9-12, amplification with pan-microsporidial and V. corneae primers with DNA of ATCC control strains of E. hellem (ATCC 50504), E. cuniculi (ATCC 50789), E. intestinalis (ATCC 50651) and V. corneae (ATCC 50505), respectively, producing 1200 and 472 bp products; MW, 20 kb DNA ladder molecular mass marker. (b) Evaluation of the sensitivity of the primer sets. Lane NC1, negative control for DNA extraction; lane NC2, negative control for reagent mixture; lane 1, amplified products of the undiluted (neat) template DNA of the positive controls; lanes 2-10, amplified products with serial tenfold dilutions of the template DNA of the positive controls [the amplified product (1200 bp) with pan-microsporidial primers with the lowest concentration (10 pg) of template DNA of E. hellem (ATCC 50504) is shown in lane 6; the amplified product (472 bp) with V. corneae species-specific primers with the lowest concentration (1 pg) of template DNA of V. corneae (ATCC 50505)] is shown in lane 7; lane PC, positive control with the amplified product (1200 bp) with pan-microsporidial primer sets with the DNA of E. hellem (ATCC 50504) and the amplified product (472 bp) with V. corneae species-specific primers with the DNA of V. corneae (ATCC 50505); MW, 20 kb DNA ladder molecular mass marker. (c) Detection of genomes of microsporidia and V. corneae utilizing dPCR with combined pan-microsporidial and V. corneae speciesspecific primers sets and DNA extracted from corneal scrapes of clinically suspected cases of microsporidial keratitis. Lanes 1-4, 6-8, 11, 12, amplified products with both pan-microsporidial (1200 bp) and V. corneae species-specific primer sets (472 bp) with DNA extracted from samples from nine of the study subjects; lanes 5, 9, 10, an absence of bands indicates negative amplification with primer sets with DNA extracted from samples from three of the study subjects.
screening of clinical specimens for microsporidia. Two sets of primer were used in our novel dPCR for targeting both the genus of microsporidia and the species of V. corneae. The genus-specific or pan-microsporidial primers amplified the region between sequence positions 1 and~1205 of the SSU-rRNA gene of microsporidial species, producing 1200 bp products from the DNA of nine study subjects, whereas, the species-specific primers for V. corneae, which were novel and primers designed by us, amplified the region between sequence positions 191 and 662 of the SSU-rRNA gene of V. corneae, [which was complementary with the reference sequence of V. corneae (GenBank accession no. L39112)] and produced 472 bp amplicons from the DNA of six study subjects, as well as showing a positive amplification with genus-specific (pan-microsporidial) primer sets.
Diagnoses of microsporidial infections are primarily based on the identification of microsporidial spores in clinical samples using light microscopy, but genus and species differentiation are uncertain (Sharma et al., 2011) . In the present analysis, of the 12 clinically suspected microsporidial keratitis samples, corneal scrapes from 6 cases showed positive results for microsporidia by smear-based light microscopy examinations revealing a uniform oval shape, and a non-budding sporulant nature, which helped to differentiate them from bacteria and yeasts. The spores stained strongly with Gram-stain and modified ZiehlNeelsen acid-fast staining and were highly remarkable. Spores are the only easily recognizable stage in microsporidia and which can survive outside their host cells (Vavra & Larsson, 1999) . Spores range in size from 1 to 40 mm, and can be spherical, ovoid, rod-shaped or crescent shaped, although most are ovoid. The classification of microsporidia in humans has depended on transmission electron microscopy techniques, and this remains the gold standard for the identification and speciation of microsporidia; however, it is not suitable for use in routine diagnosis. Apart from being subjective, detection of microsporidial spores in smears requires expertise and training, and in addition, the species of microsporidia cannot be determined by these staining techniques. Furthermore, culturing of microsporidia in mammalian cell lines is costly incorporating time-consuming procedures, which are prone to failure with specimens from unsterile sites (Franzen & Müller, 2001) . Therefore, the molecular biology of microsporidia has drawn attention for use for the accurate detection and speciation of isolates from clinical specimens. The data presented here clearly show that pan-microsporidial primers and species-specific primers of V. corneae can be used for the determination of both the genus and species of V. corneae simultaneously by utilizing a novel dPCR for corneal specimens. In addition, the analysis presented also underlines the superiority of dPCR by providing a higher diagnostic rate (75 %) over microscopy diagnosis (50 %). Also, considering the reagent consumption, test cost, duration of time and requirement of thermalcyclers for the amplification of two genomes, dPCR has a distinct advantage over conventional PCR in rapid, simultaneous identification of the genus of microsporidia and of V. corneae.
For the taxonomic system of microsporidia, both rRNA genes and protein-coding DNA sequences have been used. By using sequencing analysis, it has been shown that Nosema trichoplusiae is a synonym for Nosema bombycis based on the sequences of the SSU-rRNA encoding region (Pieniazek et al., 1996) . Nucleotide sequences of the SSUrRNA of microsporidial species have been published in NCBI databases and are accessible via the GenBank database. These are helpful in designing new primers for the identification of unknown microsporidial species. Here, by using the GenBank database, we have designed species-specific primers for the amplification of the V. corneae genome and for the sequencing of the PCR products. The sequencing analysis revealed six novel strains of V. corneae and the sequences of their SSUrRNA genes are accessible via the GenBank database (accession numbers JQ087416-JQ087421), and will be helpful for developing newer identification tools. Sequencebased identification relies on limited, yet phylogenetically informative, SSU-rRNA sequence variation between related bacterial taxa. The entire SSU-rRNA gene of microsporidia is~1550 bp in length; however, partial sequencing of SSU-rRNA generally provides sufficient taxonomic information while limiting costs. Partial SSU-rRNA sequences can be compared with sequences of V. corneae available in GenBank to determine the species with maximum similarity. For most taxa, sequence identity .99 % with a valid reference sequence is required for species-level identification.
The phylogeny of various species of microsporidia has been reported based on the sequence data of the whole SSU-rRNA gene obtained by PCR with primers amplifying the region between sequence positions 18 and 1537, complementary to the conserved region of SSU-rRNA gene at the 39 and 59 ends (Baker et al., 1995) . Results of bio-informatics analysis describe the sequence difference between V. corneae (formerly Nosema corneum) and N. bombycis, and it seems clear that V. corneae is unrelated to other Nosema spp. Baker et al. (1995) placed V. corneae in the Endoreticularis group because the parasite is most closely related to Endoreticulatus schubergi (7.3 % distance). This supports the reclassification of N. corneum to a new genus as V. corneae, which was carried out based on the ultrastructure of developmental stages in the livers of experimentally infected athymic mice (the diplokaryotic arrangement of the nuclei was the only characteristic that conformed to the description of the genus Nosema) (Silveira & Canning, 1995) . Similarly, the degree of sequence homology of the SSU-rRNA gene from E. intestinalis, E. cuniculi, E. hellem and Enterocytozoon bieneusi analysed by pairwise comparison with the BESTFIT program, after HphI and BsiHKAI restriction enzyme digestion of the amplified DNA, have been depicted by Hartskeerl et al. (1993 Hartskeerl et al. ( , 1995 who concluded that E. cuniculi, E. hellem, and E. intestinalis belong to the same genus and proposed the reclassification of Septata intestinalis to E. intestinalis. The taxonomy of microsporidia has undergone several changes during the last few years and will continue to change significantly in the near future when new DNA-based data are incorporated into new classification systems. Therefore, new molecular techniques have led not only to the discovery of new organisms but also to the elimination of an old organism.
Accurate identification up to the species level is possible through sequencing, which requires the use of long sequencing runs and time-consuming processes, and is becoming mandatory for the specific management of ocular microsporidiosis. Therefore, the utilization of species-specific primers is an elegant alternative for a sequencing methodology. This report is believed to be the first of its kind that validates a novel dPCR, a more sensitive and specific method, which depends less on more complicated methods, which will help in the reliable and quick diagnosis of microsporidiosis, including species determination. This systematic approach for the recognition of novel species with potential diagnostic or therapeutic relevance provides a basis for epidemiological surveys and improvement of sequence databases that may lead to identification of new clinical entities.
